Geode Capital Management’s BioAtla BCAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Buy |
492,259
+12,991
| +3% | +$5.15K | ﹤0.01% | 3885 |
|
|
2025
Q1 | $166K | Buy |
479,268
+59,270
| +14% | +$20.6K | ﹤0.01% | 3897 |
|
|
2024
Q4 | $248K | Buy |
419,998
+14,783
| +4% | +$8.74K | ﹤0.01% | 3825 |
|
|
2024
Q3 | $713K | Buy |
405,215
+650
| +0.2% | +$1.14K | ﹤0.01% | 3471 |
|
|
2024
Q2 | $554K | Sell |
404,565
-518,373
| -56% | -$710K | ﹤0.01% | 3533 |
|
|
2024
Q1 | $3.18M | Buy |
922,938
+18,858
| +2% | +$64.9K | ﹤0.01% | 2925 |
|
|
2023
Q4 | $2.22M | Buy |
904,080
+51,962
| +6% | +$128K | ﹤0.01% | 3060 |
|
|
2023
Q3 | $1.45M | Buy |
852,118
+21,042
| +3% | +$35.8K | ﹤0.01% | 3185 |
|
|
2023
Q2 | $2.49M | Buy |
831,076
+455,642
| +121% | +$1.37M | ﹤0.01% | 3043 |
|
|
2023
Q1 | $1.01M | Buy |
375,434
+23,137
| +7% | +$62K | ﹤0.01% | 3343 |
|
|
2022
Q4 | $2.91M | Buy |
352,297
+81,138
| +30% | +$669K | ﹤0.01% | 2916 |
|
|
2022
Q3 | $2.09M | Buy |
271,159
+90,277
| +50% | +$695K | ﹤0.01% | 3073 |
|
|
2022
Q2 | $515K | Sell |
180,882
-30,207
| -14% | -$86K | ﹤0.01% | 3741 |
|
|
2022
Q1 | $1.06M | Sell |
211,089
-78,305
| -27% | -$391K | ﹤0.01% | 3595 |
|
|
2021
Q4 | $5.68M | Buy |
289,394
+100,767
| +53% | +$1.98M | ﹤0.01% | 2830 |
|
|
2021
Q3 | $5.55M | Sell |
188,627
-14,720
| -7% | -$433K | ﹤0.01% | 2844 |
|
|
2021
Q2 | $8.62M | Buy |
203,347
+8,395
| +4% | +$356K | ﹤0.01% | 2567 |
|
|
2021
Q1 | $9.91M | Buy |
194,952
+177,513
| +1,018% | +$9.02M | ﹤0.01% | 2377 |
|
|
2020
Q4 | $593K | Buy |
+17,439
| New | +$593K | ﹤0.01% | 3541 |
|